Dr.Chou is a board-certified neurologist with subspecialty training and board certifications in critical care and vascular neurology.She is a faculty neurologist at Brigham and Women’s Hospital, an Assistant Professor in Neurology at Harvard Medical School, and a research associate at the Neuroprotection Research Laboratory and the Clinical Proteomics Research Center at Massachusetts General Hospital. Her clinical practice focuses on patients with critical injuries to their central nervous system. Her research focuses on the use of human molecular biomarkers to probe mechanisms involved in acute brain injury such as subarahcnoid hemorrhage (SAH). She is funded with a K23 award, and the goals of this work include: 1) to better define human pathophysiology of SAH-related vasospasm and brain injury using molecular biomarkers, and 2) to develop novel diagnostic molecular biomarkers in SAH, and 3) to define novel molecular therapeutic targets for secondary brain injury in SAH. I also participate as co-investigators in multicenter clinical trials in acute brain injuries including ischemic stroke, intracerebral hemorrhage, SAH, and traumatic brain injury.